L. Otten

3.8k citations
23 papers · 2.3k indexed · 1 hit paper · h-index 15

Impact in

  • Immunology top 1%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
    • Immune Response and Inflammation
    • interferon and immune responses
    • IL-33, ST2, and ILC Pathways
    • Immunodeficiency and Autoimmune Disorders
  • Oncology top 10%
    • Cytokine Signaling Pathways and Interactions

Papers in

    • Immune Cell Function and Interaction 11
    • T-cell and B-cell Immunology 11
    • Immunotherapy and Immune Responses 10
    • Immune Response and Inflammation 3
    • Immunodeficiency and Autoimmune Disorders 2
    • IL-33, ST2, and ILC Pathways 2
    • Immune responses and vaccinations 2
    • Neuroinflammation and Neurodegeneration Mechanisms 2

L. Otten

23 papers receiving 2.3k citations

Hit Papers

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome) 1993 · 725 citations
7251993202620042015200400600

Peers

L. Otten
Comparison fields: 5 of 90
  • Immunology 1.8k
  • Oncology 417
  • Immunology and Allergy 60
  • Cancer Research 141
  • Virology 43
Replace Nigel D. L. Savage with:
Nigel D. L. Savage Netherlands
Andreas Limmer Germany
Isabel Ferrero Switzerland
Neil A. Fanger United States
Micah J. Benson United States
Jörn C. Albring Germany
Megan Barnden Australia
Christophe Arpin France
Priyanka Sathe Australia
Jhagvaral Hasbold Australia
L. Otten relative to Nigel D. L. Savage Netherlands Nigel D. L. Savage's profile →
Citations per field
00.5×1.5×
Nigel D. L. Savage · 1×
Citations per year

Countries citing papers authored by L. Otten

Since Specialization
Citations

This map shows the geographic impact of L. Otten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Otten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Otten more than expected).

Fields of papers citing papers by L. Otten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Otten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Otten. The network helps show where L. Otten may publish in the future.

Co-authorship network

The 25 scholars most cited alongside L. Otten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with L. Otten Line = papers co-authored together L. Otten links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 2012112
2
Pillars Article: Complementation Cloning of an MHC Class II Transactivator Mutated in Hereditary MHC Class II Deficiency (or Bare Lymphocyte Syndrome). Cell 1993. 75: 135–146.
20076
3 2007171
4 20073
5 200746
6
TCRgamma silencing during alphabeta T cell development depends upon pre-TCR-induced proliferation.
20061
7 200623
8 20063
9 200616
10 2004259
11 2004226
12 200440
13 200334
14 20029
15 200231
16 200063
17 20002
18 1998105
19 1998311
20
Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
Hit paper breakdown →
1993725

About L. Otten

L. Otten is a scholar working on Immunology, Neurology, Microbiology, Small Animals and Oncology, having authored 23 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (11 papers), Immunotherapy and Immune Responses (10 papers), Immune Response and Inflammation (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Immune responses and vaccinations (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). The work is most often cited by research in Immunology (1.8k citations), Oncology (417 citations), Immunology and Allergy (60 citations), Cancer Research (141 citations) and Virology (43 citations). L. Otten has collaborated with scholars based in Switzerland, France and United States. Frequent co-authors include Bernard Mach, Viktor Steimle, Madeleine Zufferey, Annick Mühlethaler‐Mottet, Hans Acha‐Orbea, Walter Reith, Tobias Suter, Salomé LeibundGut‐Landmann, Isabel Ferrero and Jean‐Marc Waldburger. Their work appears in journals such as European Journal of Immunology, The Journal of Immunology, Immunity, Proceedings of the National Academy of Sciences and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026